Torrent Pharmaceuticals Limited Unclassified
FDA Approved Drugs

Torrent Pharmaceuticals Limited Unclassified

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Unclassified
  • Total Records 13
  • Latest Approval Date -
  • Data Source FDA
  • First Approval Date -
All
326
View
Unclassified
13
View
Discontinued
148
View
RX
165
View
Company Overview

Company

Torrent Pharmaceuticals Limited Unclassified

Country

India

Email

Social Profiles

LinkedIn X / Twitter
Company Snapshot

Torrent Pharmaceuticals Limited Unclassified

Off. Ashram Road, Ahmedabad - 380 009, Gujarat

India

www.torrentpharma.com/ View on Map
FDA Approved Drug Records ( 13 records )
-
Unclassified Application: 210160

Drug Name

ALOGLIPTIN; METFORMIN HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 12.5MG BASE;500MG

Approval Date

-

210160 / 1

Active Ingredient

ALOGLIPTIN; METFORMIN HYDROCHLORIDE

Application Number

210160

Product Number

1

Dosage Form

-

Strength

EQ 12.5MG BASE;500MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 210160

Drug Name

ALOGLIPTIN; METFORMIN HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 12.5MG BASE;1GM

Approval Date

-

210160 / 2

Active Ingredient

ALOGLIPTIN; METFORMIN HYDROCHLORIDE

Application Number

210160

Product Number

2

Dosage Form

-

Strength

EQ 12.5MG BASE;1GM

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 220375

Drug Name

RUXOLITINIB

Product Number

2

Dosage Form

-

Strength

20MG

Approval Date

-

220375 / 2

Active Ingredient

RUXOLITINIB

Application Number

220375

Product Number

2

Dosage Form

-

Strength

20MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 220375

Drug Name

RUXOLITINIB

Product Number

3

Dosage Form

-

Strength

15MG

Approval Date

-

220375 / 3

Active Ingredient

RUXOLITINIB

Application Number

220375

Product Number

3

Dosage Form

-

Strength

15MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 220375

Drug Name

RUXOLITINIB

Product Number

4

Dosage Form

-

Strength

10MG

Approval Date

-

220375 / 4

Active Ingredient

RUXOLITINIB

Application Number

220375

Product Number

4

Dosage Form

-

Strength

10MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 220375

Drug Name

RUXOLITINIB

Product Number

5

Dosage Form

-

Strength

5MG

Approval Date

-

220375 / 5

Active Ingredient

RUXOLITINIB

Application Number

220375

Product Number

5

Dosage Form

-

Strength

5MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 91654

Drug Name

VALSARTAN; HYDROCHLOROTHIAZIDE

Product Number

1

Dosage Form

-

Strength

80MG; 12.5MG

Approval Date

-

91654 / 1

Active Ingredient

VALSARTAN; HYDROCHLOROTHIAZIDE

Application Number

91654

Product Number

1

Dosage Form

-

Strength

80MG; 12.5MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 91654

Drug Name

VALSARTAN; HYDROCHLOROTHIAZIDE

Product Number

2

Dosage Form

-

Strength

160MG; 12.5MG

Approval Date

-

91654 / 2

Active Ingredient

VALSARTAN; HYDROCHLOROTHIAZIDE

Application Number

91654

Product Number

2

Dosage Form

-

Strength

160MG; 12.5MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 91654

Drug Name

VALSARTAN; HYDROCHLOROTHIAZIDE

Product Number

3

Dosage Form

-

Strength

160MG; 25MG

Approval Date

-

91654 / 3

Active Ingredient

VALSARTAN; HYDROCHLOROTHIAZIDE

Application Number

91654

Product Number

3

Dosage Form

-

Strength

160MG; 25MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 91654

Drug Name

VALSARTAN; HYDROCHLOROTHIAZIDE

Product Number

4

Dosage Form

-

Strength

320MG; 12.5MG

Approval Date

-

91654 / 4

Active Ingredient

VALSARTAN; HYDROCHLOROTHIAZIDE

Application Number

91654

Product Number

4

Dosage Form

-

Strength

320MG; 12.5MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 91654

Drug Name

VALSARTAN; HYDROCHLOROTHIAZIDE

Product Number

5

Dosage Form

-

Strength

320MG; 25MG

Approval Date

-

91654 / 5

Active Ingredient

VALSARTAN; HYDROCHLOROTHIAZIDE

Application Number

91654

Product Number

5

Dosage Form

-

Strength

320MG; 25MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 220221

Drug Name

VERICIGUAT

Product Number

2

Dosage Form

-

Strength

2.5MG

Approval Date

-

220221 / 2

Active Ingredient

VERICIGUAT

Application Number

220221

Product Number

2

Dosage Form

-

Strength

2.5MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 220221

Drug Name

VERICIGUAT

Product Number

3

Dosage Form

-

Strength

10MG

Approval Date

-

220221 / 3

Active Ingredient

VERICIGUAT

Application Number

220221

Product Number

3

Dosage Form

-

Strength

10MG

Approval Date

-

Regulatory Status

Unclassified

Related Databases
  • FDA Inspections
    23 View
  • EDQM CEP
    12 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    1 View
  • FDA Approved Drugs Database
    326 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
13 total
  • Unclassified
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

ALOGLIPTIN; METFORMIN HYDROCHLORIDE

Application Number

210160

Product Number

1

Active Ingredient

ALOGLIPTIN; METFORMIN HYDROCHLORIDE

Dosage Form

-

Strength

EQ 12.5MG BASE;500MG

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.